Smirnikhina SA - Search Results

1

Rational Design of ssODN to Correct Mutations by Gene Editing.

Volodina OV, Anuchina AA, Zainitdinova MI, Evtushenko NA, Lavrov AV, Smirnikhina SA. Volodina OV, et al. Among authors: smirnikhina sa. Biochemistry (Mosc). 2022 May;87(5):464-471. doi: 10.1134/S0006297922050078. Biochemistry (Mosc). 2022. PMID: 35790380

2

[Methods for detection of methylated cytosine residues in DNA].

Smirnikhina SA, Lavrov AV. Smirnikhina SA, et al. Mol Biol (Mosk). 2009 May-Jun;43(3):387-91. Mol Biol (Mosk). 2009. PMID: 19634258 Review. Russian.

3

[VEGF gene expression in transfected human multipotent stromal cells].

Smirnikhina SA, Lavrov AV, Bochkov NP. Smirnikhina SA, et al. Vestn Ross Akad Med Nauk. 2011;(9):54-7. Vestn Ross Akad Med Nauk. 2011. PMID: 22145373 Russian.

4

Dynamics of elimination of plasmids and expression of VEGF121 gene transfected into human mesenchymal stem cells by different methods.

Smirnikhina SA, Lavrov AV, Bochkov NP. Smirnikhina SA, et al. Bull Exp Biol Med. 2011 May;151(1):121-5. doi: 10.1007/s10517-011-1272-5. Bull Exp Biol Med. 2011. PMID: 22442816

5

Dioxidine-induced changes in genome-wide DNA methylation in a culture of peripheral blood lymphocytes.

Smirnikhina SA, Voronina ES, Lavrov AV, Bochkov NP. Smirnikhina SA, et al. Bull Exp Biol Med. 2013 Jun;155(2):224-7. doi: 10.1007/s10517-013-2119-z. Bull Exp Biol Med. 2013. PMID: 24130996

6

[Mutagen influence with different mechanisms of action on DNA global methylation in human whole-blood lymphocytes in vitro].

Smirnikhina SA, Voronina ES, Strelnikov VV, Tanas AS, Lavrov AV. Smirnikhina SA, et al. Genetika. 2013 Jul;49(7):877-83. doi: 10.7868/s001667581306012x. Genetika. 2013. PMID: 24450157 Russian.

7

Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients.

Smirnikhina SA, Lavrov AV, Chelysheva EY, Adilgereeva EP, Shukhov OA, Turkina A, Kutsev SI. Smirnikhina SA, et al. Leuk Lymphoma. 2016 Jul;57(7):1669-76. doi: 10.3109/10428194.2015.1132420. Epub 2016 Jan 12. Leuk Lymphoma. 2016. PMID: 26759060

8

Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia.

Lavrov AV, Chelysheva EY, Smirnikhina SA, Shukhov OA, Turkina AG, Adilgereeva EP, Kutsev SI. Lavrov AV, et al. Among authors: smirnikhina sa. BMC Genet. 2016 Jan 27;17 Suppl 1(Suppl 1):14. doi: 10.1186/s12863-015-0308-7. BMC Genet. 2016. PMID: 26822197 Free PMC article.

9

Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.

Lavrov AV, Ustaeva OA, Adilgereeva EP, Smirnikhina SA, Chelysheva EY, Shukhov OA, Shatokhin YV, Mordanov SV, Turkina AG, Kutsev SI. Lavrov AV, et al. Among authors: smirnikhina sa. PLoS One. 2017 Sep 13;12(9):e0182901. doi: 10.1371/journal.pone.0182901. eCollection 2017. PLoS One. 2017. PMID: 28902850 Free PMC article.

10

Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation.

Smirnikhina SA, Chelysheva EY, Lavrov AV, Kochergin-Nikitsky KS, Mozgovoy IV, Adilgereeva EP, Shukhov OA, Petrova AN, Bykova AV, Abdullaev AO, Turkina AG, Kutsev SI. Smirnikhina SA, et al. Leuk Lymphoma. 2018 Oct;59(10):2512-2515. doi: 10.1080/10428194.2018.1434880. Epub 2018 Feb 9. Leuk Lymphoma. 2018. PMID: 29424604 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page